4.6 Review

Pathophysiology of parkinsonism

Journal

CLINICAL NEUROPHYSIOLOGY
Volume 119, Issue 7, Pages 1459-1474

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.clinph.2008.03.017

Keywords

Parkinson's disease; parkinsonism; basal ganglia; dopamine; GABA; glutamate; putamen; globus pallidus; subthalamic nucleus; substantia nigra; bursts; oscillations

Funding

  1. NCRR NIH HHS [P51 RR000165-477545, P51 RR000165-477546, P51 RR000165-460261, P51 RR000165-457283, RR-000165, P51 RR000165, P51 RR000165-477518, P51 RR000165-477456] Funding Source: Medline
  2. NINDS NIH HHS [R01 NS049474-04, R01 NS049474, NS049474, R01 NS042250, NS042250, R01 NS054976-03, NS054976, R01 NS054976, R01 NS042250-05] Funding Source: Medline

Ask authors/readers for more resources

The motor signs of Parkinson's disease are thought to result in large part from a reduction of the level of dopamine in the basal ganglia. Over the last few years, many of the functional and anatomical consequences of dopamine loss in these structures have been identified, both in the basal ganglia and in related areas in thalamus and cortex. This knowledge has contributed significantly to our understanding of the link between the degeneration of dopamine neurons in the midbrain and the development of parkinsonism. This review discusses the evidence that implicates electrophysiologic changes (including altered discharge rates, increased incidence of burst firing, interneuronal synchrony, oscillatory activity, and altered sensorimotor processing) in basal ganglia, thalamus, and cortex, in parkinsonism. From these studies, parkinsonism emerges as a complex network disorder, in which abnormal activity in groups of neurons in the basal ganglia strongly affects the excitability, oscillatory activity, synchrony and sensory responses of areas of the cerebral cortex that are involved in the planning and execution of movement, as well as in executive, limbic or sensory functions. Detailed knowledge of these changes will help us to develop more effective and specific symptomatic treatments for patients with Parkinson's disease. (C) 2008 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available